Back to Search
MIRIAM LANGO, M.D.
M.D.
Otolaryngology Physician
NPI: 1457372153IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
S4012(TX)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (13)
Controversies in surgical management of the node-positive neck after chemoradiation.
PMID 19028342·Semin Radiat Oncol·2009
6-review
Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
PMID 18853450·Head Neck·2009
8-other
The role of neck dissection in the combined modality therapy setting.
PMID 18544438·Semin Oncol·2008
6-review
Idiopathic hypereosinophilic syndrome with skull base involvement.
PMID 17494680·AJNR Am J Neuroradiol·2007
5-case
Intensity-modulated radiotherapy for early larynx cancer: is there a role?
PMID 17448864·Int J Radiat Oncol Biol Phys·2007
8-other
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
PMID 16951222·Clin Cancer Res·2006
7-preclinical
Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells.
PMID 14519647·Clin Cancer Res·2003
7-preclinical
Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
PMID 11880476·J Natl Cancer Inst·2002
7-preclinical
Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
PMID 11479234·Cancer Res·2001
7-preclinical
Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.
PMID 11307060·Curr Opin Oncol·2001
6-review
TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
PMID 11127578·Gene Ther·2000
4-observational
Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma.
PMID 10979119·Arch Otolaryngol Head Neck Surg·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1457372153
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 13
Are you this provider?
Claim Your Profile